Provention bio stock trading halted today

Red bank, n.j., may 27, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that nasdaq has halted trading of the company's common stock.

PRVB Ratings Summary

PRVB Quant Ranking